About POCT POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life. The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex. These devices are used to test cardiac biomarkers, blood coagulation, platelet function, HIV, hemoglobin concentration, ad five-part differential blood count. Technavio's analysts forecast the POCT market in the US to grow at a CAGR of 5.88% over the period 2014-2019. Covered in this report The report covers the current scenario and the growth prospects of... Research Beam Model: Research Beam Product ID: 359274 2500 USD New
POCT Market in the US 2015-2019
 

POCT Market in the US 2015-2019

POCT Market in the US 2015-2019

Category : Diagnostic and Biotech
Published On : November  2015
Pages : 70

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About POCT
POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life. 
The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex. These devices are used to test cardiac biomarkers, blood coagulation, platelet function, HIV, hemoglobin concentration, ad five-part differential blood count.

Technavio's analysts forecast the POCT market in the US to grow at a CAGR of 5.88% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the POCT market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of POCT diagnostic devices. The market is segmented based on application:
 Blood glucose testing
 Infectious disease testing
 Cardiac markers testing
 Pregnancy and fertility testing
 Blood gas/electrolyte testing
 Tumour markers testing
 Urinalysis testing
 Cholesterol testing

Technavio's report, POCT Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the key vendors in the market. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors
 Abbott diagnostics
 Alere
 Roche Diagnostics 
 Siemens Diagnostics

Other prominent vendors
 Abaxis 
 Acon Laboratories
 Avioq
 Bio-Rad Laboratories 
 Cavidi
 Cepheid
 Chembio Diagnostic Systems
 Clarity Diagnostics
 Hologic
 i-Sens
 Landwind Medical
 Mindray
 Nipro Diagnostics 
 Randox Laboratories
 Span Diagnostics
 Sysmex
 Thermo Fisher Scientific 
 Trivitron Healthcare
 URIT 

Market driver
 North America free trade agreement
 For a full, detailed list, view our report

Market challenge
 Limitation of POCT products
 For a full, detailed list, view our report

Market trend
 Key role of USAMRIID
 For a full, detailed list, view our report

Key questions answered in this report
 What will the market size be in 2019 and what will the growth rate be
 What are the key market trends
 What is driving this market
 What are the challenges to market growth
 Who are the key vendors in this market space
 What are the market opportunities and threats faced by the key vendors
 What are the strengths and weaknesses of the key vendors
PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview

PART 06: Healthcare reform in US
Introduction of PPACA
Five forces analysis

PART 07: Market segmentation by application
Blood glucose testing market in US
Infectious disease testing market in US
Cardiac marker testing market in US
Coagulation testing market in US
Pregnancy and fertility testing market in US
Blood gas/electrolyte testing market in US
Tumor marker testing market in US
Urinalysis testing market in US
Cholesterol testing market in US

PART 08: Market drivers
Influence of NAFTA
Demand for rapid and automated diagnostics
POCT at home
Technological innovations
Collaborations and M&A to enhance POCT technology

PART 09: Impact of drivers

PART 10: Market challenges
Issues of intellectual property rights
Threat of low-cost products
Product recalls

PART 11: Impact of drivers and challenges

PART 12: Market trends
Shift toward patient-centered model
Low-cost microfluidic devices for POCT
Growing popularity of portable POCT products
Role of USAMRIID

PART 13: Vendor landscape
Competitive scenario
Abbott Diagnostics
Alere
Roche Diagnostics
Siemens Diagnostics
Other prominent vendors

PART 14: Key vendor analysis
Abbott Diagnostics
Alere
Roche Diagnostics
Siemens Healthcare

PART 15: Appendix
List of abbreviations

PART 16: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: POCT market in US 2014-2019 ($ millions)
Exhibit 03: PPACA benefits for US citizens
Exhibit 04: Comparison of US healthcare provision pre and post reform
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of POCT market in US by application
Exhibit 07: Blood glucose testing market in US 2014-2019 ($ millions)
Exhibit 08: Infectious disease testing market in US 2014-2019 ($ millions)
Exhibit 09: Cardiac marker testing market in US 2014-2019 ($ millions)
Exhibit 10: Coagulation testing market in US 2014-2019 ($ millions)
Exhibit 11: Pregnancy and fertility testing market in US 2014-2019 ($ millions)
Exhibit 12: Blood gas/electrolyte testing market in US 2014-2019 ($ millions)
Exhibit 13: Tumor marker testing market in US 2014-2019 ($ millions)
Exhibit 14: Urinalysis testing market in US 2014-2019 ($ millions)
Exhibit 15: Cholesterol testing market in US 2014-2019 ($ millions)
Exhibit 16: Segmentation of POCT market in US by application 2014POCT market in US by application 2014
Exhibit 17: Impact of drivers
Exhibit 18: Impact of drivers and challenges
Exhibit 19: Abbott Diagnostics: Key takeaways
Exhibit 20: Alere: Key takeaways
Exhibit 21: Roche Diagnostics: Key takeaways
Exhibit 22: Siemens Diagnostics: Key takeaways
Exhibit 23: Abbott Diagnostics: Key business offerings
Exhibit 24: Alere: Business Segmentation by revenue 2014
Exhibit 25: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 26: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 29: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 30: Siemens Healthcare: Business segmentation
Exhibit 31: Siemens Healthcare: Geographical segmentation by revenue 2014

Enquiry Before Buy